Literature DB >> 818022

Enhancement activity of anti-mycobacterial sera in experimental Mycobacterium bovis (BCG) infection in mice.

A Forget, J C Benoit, R Turcotte, N Gusew-Chartrand.   

Abstract

The passive transfer of rabbit anti-mycobacterial immunoglobulins was directed against either living or soluble extracts of Mycobacterium tuberculosis strain H37Rv, which promotes the multiplication of the BCG strain of M. tuberculosis in the spleen of mice infected with low doses of this latter strain. This enhancing effect was reduced significantly when antisera were absorbed with living BCG. Moreover, such treatment led to the removal of all hemagglutinating antibodies when antisera were tested against either BCG or H37Rv soluble extracts. Therefore, it is most probable that the enhancing effect is related to the presence of mycobacterial antibodies.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 818022      PMCID: PMC420756          DOI: 10.1128/iai.13.5.1301-1306.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  STUDIES ON THE ANTIGENIC STRUCTURE OF MYCOBACTERIA. I.

Authors:  K A JENSEN; I KIAER; L LUNDBERG
Journal:  Acta Pathol Microbiol Scand       Date:  1964

2.  [SURVIVAL AND MULTIPLICATION OF BCG AND OF THE TUBERCLE BACILLUS IN MICE. IV. SURVIVAL AND MULTIPLICATION OF BCG DAUGHTER STRAINS AS A FUNCTION OF TIME AND DOSAGE].

Authors:  J C BENOIT; M PANISSET
Journal:  Acta Tuberc Pneumol Scand       Date:  1963

3.  [OBTAINING BY FILTRATION OF BACILLI ISOLATED FROM SUSPENSIONS CONTAINING BACILLARY AGGREGATES. PERFECTION OF A QUANTITATIVE METHOD].

Authors:  J C BENOIT; M QUEVILLON; M PANISSET
Journal:  Rev Can Biol       Date:  1963 Sep-Dec

4.  INHIBITION OF THE DEVELOPMENT OF DELAYED HYPERSENSITIVITY BY TREATMENT WITH ANTISERUM.

Authors:  A J CROWLE; C C HU
Journal:  J Immunol       Date:  1965-04       Impact factor: 5.422

5.  Studies on the antigenic structure of mycobacteria with the gel diffision technique.

Authors:  F GIMPL; J WEISSFEILER
Journal:  Acta Microbiol Acad Sci Hung       Date:  1962

6.  The in vitro detection of "cell-fixed" hemagglutinating antibodies to tuberculin purified protein derivative (PPD) in humans.

Authors:  S O FREEDMAN; R TURCOTTE; A J FISH; A H SEHON
Journal:  J Immunol       Date:  1963-01       Impact factor: 5.422

7.  Immunological enhancement of tumor homografts in mice: a review.

Authors:  N KALISS
Journal:  Cancer Res       Date:  1958-10       Impact factor: 12.701

8.  [Survival and multiplication of BCG and of tuberclebacilli in the mouse as a function of time. I. Study of a measurement method].

Authors:  M PANISSET; J C BENOIT
Journal:  Ann Inst Pasteur (Paris)       Date:  1959-10

9.  The enumeration of nonpathogenic viable tubercle bacilli from the organs of mice.

Authors:  J L SEVER; G P YOUMANS
Journal:  Am Rev Tuberc       Date:  1957-02

10.  Antibody formation. I. The suppression of antibody formation by passively administered antibody.

Authors:  J W UHR; J B BAUMANN
Journal:  J Exp Med       Date:  1961-05-01       Impact factor: 14.307

View more
  12 in total

1.  Antibody repertoire against culture filtrate antigens in wild house mice infected with Mycobacterium bovis BCG.

Authors:  K Huygen; K Palfliet; F Jurion; C Lenoir; J P van Vooren
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

2.  Repertoires of antibodies to culture filtrate antigens in different mouse strains infected with Mycobacterium bovis BCG.

Authors:  K Huygen; L Ljungqvist; R ten Berg; J P Van Vooren
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

Review 3.  Genetic aspects of innate resistance and acquired immunity to mycobacteria in inbred mice.

Authors:  E Buschman; A S Apt; B V Nickonenko; A M Moroz; M H Averbakh; E Skamene
Journal:  Springer Semin Immunopathol       Date:  1988

4.  Influence of genes from the major histocompatibility complex on the antibody repertoire against culture filtrate antigens in mice infected with live Mycobacterium bovis BCG.

Authors:  K Huygen; A Drowart; M Harboe; R ten Berg; J Cogniaux; J P Van Vooren
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

5.  Studies on the effect of mycobacterial antibodies on skin-test reactivity to M. tuberculosis.

Authors:  H A Drexhage; B M Blomberg-vd Flier; W B vd Berg
Journal:  Br J Exp Pathol       Date:  1980-04

6.  Identification of B- and T-cell epitopes within the MTP40 protein of Mycobacterium tuberculosis and their correlation with the disease course.

Authors:  J C Falla; C A Parra; M Mendoza; L C Franco; F Guzmán; J Forero; O Orozco; M E Patarroyo
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

7.  Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis.

Authors:  P G Pal; M A Horwitz
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

8.  Induction and suppression of cross-reactive antituberculosis immunity after Mycobacterium lepraemurium infection of mice.

Authors:  M J Lefford; P S Logie
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

Review 9.  A Case for Antibodies as Mechanistic Correlates of Immunity in Tuberculosis.

Authors:  Jeffrey Y Kawahara; Edward B Irvine; Galit Alter
Journal:  Front Immunol       Date:  2019-05-09       Impact factor: 7.561

Review 10.  Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis.

Authors:  A Glatman-Freedman; A Casadevall
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.